Dade introduces ESbetaL enzymes panel:
This article was originally published in Clinica
Executive Summary
Dade Behring has introduced to its MicroScan line of products a new panel for confirming the presence of ESbetaL enzymes that have already been detected by screening methods. The ESbetaL (extended-spectrum beta-lactamase) confirmation panel is designed to help microbiology laboratories identify the presence of bacterial strains that produce the enzyme. These strains include E coli, K pneumoniae and K oxytoca, each of which may be clinically resistant to therapy with penicillins, cephalosporins and aztreonam.